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Membrane proteinAmantadine-sensitive proton uptake by liposomes is currently the preferred method of demonstrating M2
functionality after reconstitution, to validate structural determination with techniques such as solid-state NMR.
With strong driving forces (two decades each of both [K+] gradient-induced membrane potential and [H+]
gradient), M2(22–62) showed a transport rate of 78 H+/tetramer-s (pHo 6.0, pHi 8.0, nominal Vm=−114 mV),
higher than previously measured for similar, shorter, and full-length constructs. Amantadine sensitivity of the
conductance domain at pH 6.8 was also comparable to other published reports. Proton ﬂux rate was optimal at
protein densities of 0.05–1.0% (peptide wt.% in lipid). Rundown of total proton uptake after addition of
valinomycin and CCCP, as detected by delayed addition of valinomycin, indicatedM2-induced K+ ﬂux of 0.1 K+/
tetramer-s, and also demonstrated that the K+ permeability, relative to H+, was 2.8×10−6. Transport rate,
amantadine and cyclooctylamine sensitivity, acid activation, and H+ selectivity were all consistent with full
functionality of the reconstituted conductance domain. Decreased external pH increased proton uptake with an
apparent pKa of 6.velopmental Biology, Brigham
1 7875; fax: +1 801 422 0700.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
The Inﬂuenza A virus contains a 97-residue, single-pass integral
membraneprotein,M2,whichassociates into tetrameric, proton-selective
ion pores in cellular (and therefore viral) membranes. This protein is the
target of the adamantane-derived antiviral drugs amantadine and
rimantadine. With the emergence of the 2009 pandemic H1N1 strain,
virtually all InﬂuenzaAstrains circulating inhumanpopulationsnowhave
acquired one or more mutations in the M2 protein which confer
amantadine resistance [1,2]. Elucidation of the structural and functional
features underlying M2 proton transport is critical to the search for new
antiﬂu drugs. Functional assays used to study this protein electrophys-
iologically have ranged from in vivo studies in transformed, M2-
expressing Xenopus oocytes [3–5] or mouse erythroleukemia cells [6] to
wholly in vitro planar bilayer [7,8] studies. When puriﬁed, reconstituted
protein is available, the currently preferred method [9] is the proteolipo-
some proton ﬂux assay, using either pH-sensitive ﬂuorophores [3,10,11]
or direct measurement of extra-liposomal pH to quantify proton inﬂux
into liposomes [12,13]. This method is not limited by the constraints of
cellular physiological tolerance, yet utilizes a more natural lipid
arrangement than a solvent-inﬂated planar bilayer or micellar environ-ment. Recently, the structure of M2 (residues 22–62) was determined in
planar lipid bilayers using solid-state NMR spectroscopy [14]. Here, we
assess the functionality of this peptide in a similar lipid bilayer
environment.
From reversal potentials [5,6] and related electrophysiological
calculations [5], the M2 current is exquisitely proton-selective (perme-
ability, relative to that ofNa+, of 1.6×106). Initially, qualitativemethodsof
assessing selectivity in liposomeswere used and suggested similar values
[11]. A more quantitative approach was suggested [12] and used to
establish thatM2's proton selectivity is of the same order ofmagnitude as
in erythroleukemia cells. Here the quantitative approach is fully
implemented, giving an improved estimate of M2(22–62) selectivity
and exploring the time course of vesicle depolarization byM2 transport of
K+. The concept that small but ﬁnite alkali metal transport by M2 would
be physiologically valuable for virus acidiﬁcation was highlighted in a
recent study by Årsköld and colleagues [15].
In cell expression systems, the transport rate of full-length M2 is very
low, i.e. 210 H+/s=34 aA (pHo 6.2, Vm −130 mV [16], as calculated in
[11]). Liposome assays have previously yielded much lower (N20-fold)
transport rates [3,11–13]. In these studies, either electrical or pH gradient
was used to motivate proton ﬂux. Here, we report that, when using a
combination of electrical and chemical gradients, proton ﬂux rates of M2
(22–62) in liposomes approach those measured in oocytes. The Årsköld
study showed similar levels of proton transport in liposomes [15].
Proton transport through M2 is induced by external acidiﬁcation
[17]. This is due in part to increased driving force for proton current, but
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and Weybridge [18] inﬂuenza strains show strong signs of N-terminal
acid activation, namely reduction of external/N-terminal pH reduces
outwardproton currents in spite of the increaseddriving force.Here, it is
assumed that the basic pH inside the liposomeswill blockproton uptake
by the half [11] of the tetramers whose N-termini are inside the
liposomes, so that the uptake is done only by the other half.
M2 currents are reduced by 50% when exposed to external 9 μM
amantadine (full-length protein, pH 7.5 [19]), and show similar
sensitivity to rimantadine [6], cyclooctylamine [11], and 2-[3-azaspiro
(5,5)undecanol]-2-imidazoline (BL-1743) [20]. Numerous related com-
pounds have also been shown to inhibit viral growth and/or to inhibit
M2 conductance [21–25] (for additional references, see [9]). Here we
assess the amantadine and cyclooctylamine sensitivities of M2(22–62),
exploring the block with increasingly acid external solution.
It is generally assumed that M2 is fully tetrameric in lipid bilayers,
although the monomer–tetramer equilibrium is evident in analytical
ultracentrifugation for M2 suspended in detergent micelles [26,27]. Here
weassess the speciﬁc activity ofM2(22–62) over a broad rangeof peptide
densities in liposomes to examine whether there is any departure from
constancy that would indicate incomplete tetramerization.
2. Materials and methods
2.1. Peptide expression and puriﬁcation
The M2(22–62) construct used in these liposome assays included
the transmembrane domain and post-TM amphipathic helix. The
construct, expressed in transfected E. coli BL21 (DE3), was comprised
of an N-terminal 6-histidine tag followed by the large, soluble maltose
binding protein, then a TEV-protease cleavage site, and ﬁnally the
insoluble M2(22–62) peptide. The fusion protein was collected from
the bacterial membrane fraction by solubilization with dodecylmalto-
side, and puriﬁed via afﬁnity chromatography with a Ni–NTA column.
The peptidewas cleaved from the fusion proteinwith TEV protease for
20 h. The reaction mixture was precipitated with trichloroacetic acid
and lyophilized. The cleaved M2(22–62) peptide was solubilized
using methanol and the concentration determined by absorbance at
280 nm using a generic extinction coefﬁcient (1 ml mg−1 cm−1). It
contains a fragment of the TEV cleavage site (Ser, Asn, Ala) at the N-
terminus, such that the total length is 44 amino acids, with a
calculated molecular weight of 5014.9 Da.
2.2. Liposome preparation
Liposomes were prepared by mixing chloroform-suspended E. coli
polar lipid extract (67% phosphatidylethanolamine, 23.2% phospha-
tidylglycerol, 9.8% cardiolipin, average molecular weight: 798 Da;
Avanti Polar Lipids, Alabaster, AL, USA) with the methanol-suspended
M2(22–62) peptide. The solvent was then evaporated under a steady
stream of N2 gas. The resulting clear lipid ﬁlm was placed in a vacuum
for 1–2 h to remove any remaining traces of solvent. Internal buffer
(50 mMKCl, 50 mMK2HPO4, 50 mMKH2PO4, pH 8.0, 320 mOsm) was
added to the thin ﬁlm, vortexed to form nonuniform liposomes, then
extruded through a 100-nm pore-size polycarbonate ﬁlter (Liposofast
membrane extruder, Avestin, Ottawa, Canada) at 50–60 °C. After
extrusion, samples were divided for matched-pair drug block
assessment. Amantadine or cyclooctylamine were added to liposome
and external buffers to a nominal concentration of 100 μM. The
average vesicle diameter was found to be 145±15 nm by dynamic
light scattering (Brookhaven Instruments, Holtsville, NY, USA).
2.3. Experimental protocol
The proton-uptake assay was modelled after a paradigm developed
previously [12,13]. Liposomes were diluted 100-fold (except as notedfor Fig. 1) into 3 ml of external buffer (either weak phosphate buffer:
165 mM NaCl, 0.05 mM KH2PO4/K2HPO4, pH 7, 320 mOsm, or strong
citrate buffer: 165 mM NaCl, 1.67 mM sodium citrate, 0.33 mM citric
acid, 320 mOsm, titrated appropriately for the target pH) in a 1-dram
vial. Because [K+] is negligible in the external buffer, the dilution creates
a 100× gradient in [K+] across the liposomemembrane,which yields an
electrical potential of −110 mV for a K+-selective membrane at room
temperature (after compensating for K+ activity coefﬁcients). A pH
electrode (Accumet combination electrode with calomel reference,
model 13-620-293, Fisher Scientiﬁc, Houston, TX, USA) was used to
measure proton movement into or out of the liposomes throughout the
experiment. After liposome addition, valinomycin (Sigma-Aldrich
Corp.) was added to the solution to a concentration of 30 nM to render
the membrane dominantly permeable to K+ and produce the
membrane potential. In some cases, the external buffer was acidiﬁed
with 0.1 M HCl after liposome dilution and at least 2 min before
valinomycin addition. Two minutes after valinomycin, CCCP was then
added to a concentration of 1.67 μM. Finally, two calibration aliquots of
30nEqHCl were averaged for conversion of the pH changes into nEqH+
inﬂux. In several experiments, valinomycin was again added after
complete CCCP-gradient neutralization to evaluate the time course and
size of the direct impact of the valinomycin and its ethanol carrier on the
bath pH. It was found to produce a small, fast step rise in a bath pH of
0.002 units and requiring about 2 s (depending on stirring) to reach a
new level, which was taken into account in the data analyses by
considering the ﬁrst 2 s after valinomycin to be dead time.
2.4. Analysis of potassium ﬂux rates
The rate of total signal decay was used to indicate the rate of
depolarization of liposomes deriving from K+ permeability. Because of
variability in the trapped volume between liposome preparations, this
required normalization of the total signal heights extrapolated back to the
time when the liposomes were ﬁrst exposed to a pH gradient. The total
signals from each experiment, corrected for ethanolic reagent artifacts,
were ﬁrst ﬁtted with an exponential decay function and then divided by
the respective zero-time (acidiﬁcation time) intercept for trapped volume
normalization before averaging with the other two experiments in its
group. The normalized averages were then ﬁt with a unity-amplitude
exponential decay function (solid lines on the semi-log plot), the
characteristic time of the protein-free curve was subtracted from that of
the proteoliposome curve, and the result wasmultiplied by the zero-time
intercept for theprotein-containing liposomes toobtain thedenormalized
decay due to K+ ﬂux (nmol K+/minute) through M2(22–62). This was
then divided by the total protein content in the sample (0.15 nmol
tetramers) and converted to units of seconds.
3. Results
Thedata from liposomeassays presentedhere, testingdrug sensitivity,
selectivity, acid activation and responses, andprotonﬂux rate all indicated
robust function of M2(22–62) in the E. coli lipid environment, and
demonstrate increased speciﬁc activity over previous liposome assay
reports. Fig. 1 demonstrates the high sensitivity of M2(22–62) to the
known blockers, amantadine and cyclooctylamine. After injection of
liposomes into external buffer, diluting the external [K+] by 67-fold (in
this case), the exterior is acidiﬁed to pH 6.8 (t=0 s). Proton uptake under
thesemodest gradients is initiated at t=180 s by addition of valinomycin,
giving an initial uptake rate of 4.6 H+/tetramer-s. The initial slope was
approximately halved by the presence of drugs: 10 μM amantadine
(Ki=9 μM in the full-length protein [19]) reduced proton transport by
61%. 10 μM cyclooctylamine (a blocker with potency similar to amanta-
dine) reduced transport by 50%.
The effect of amantadine block is further illustrated in Fig. 2,where the
raw uptake traces (without background subtraction) in the presence of
100 μM amantadine are shown. Without amantadine, the initial slope
-0.02
0
0.02
0.04
0.06
0.08
0.1
50 100 150 200 250 300
ch
an
ge
 in
 p
H 
time (s)
tref valinomycin
CCCP
Fig. 1. Four traces are shown: M2(22–62) proteoliposomes only (solid black line), M2
(22–62) proteoliposomes in the presence of 10 μM amantadine (dotted black line), M2
(22–62) in the presence of 10 μM cyclooctylamine (dashed gray line), and protein-free
liposomes (solid gray line). A modest linear positively sloped baseline drift has been
subtracted. Vertical axis shows change in pH relative to that at an arbitrary reference
time used in this plot to align traces vertically, t=90 s post acid addition. Horizontal
axis is time (in seconds) after external acidiﬁcation. Arrows indicate the reference time,
addition of valinomycin to 30 nM, and addition of CCCP to 1.67 μM.For the conditionsused
in this experiment (60-fold dilution of liposomes into external buffer producing K+
concentration ratio of 67 and nominal K+ Nernst potential, and thus membrane potential
after valinomycin addition, of Vm=−104 mV; 20 mg lipid: 0.2 mg protein:ml solution,
150 nm diameter vesicles, pHo 6.8, pHi 8.4), which represents a comparatively modest
driving force and acid activation, each tetramer transported 4.6 H+/s in the absence of
drugs. Amantadine treatment reduced transport by 61% and cyclooctylamine by 50%.
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account the size of the 30 nEqH+back-titration and the nominal protein
content in the sample, 0.15 nmol ofM2(22–62) tetramers—half ofwhich
are presumed to be active. Subtraction of the equivalent of 6.5 H+/
tetramer-s observed independentlywith protein-free liposomes yields an
M2 ﬂux of 33.5 H+/tetramer-s. (Here, the two-decade [K+] and [H+]
gradientswereused; thisﬂux ratewas at the lowend for the group,which
is reported more completely below). With amantadine, the initial slope
was reduced to the equivalent of 16.5 H+/tetramer-s (inset, R2=0.92).
After subtraction of an equivalent of 7.8 H+/tetramer-s for protein-free-0.002
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Fig. 2. Valinomycin-induced uptake as inhibited by 100 μM amantadine, showing the
small change in external pH under consideration. Valinomycin was added at t=0 s. A
linear baseline drift has been subtracted. Black dots: M2(22–62) proteoliposomes. Gray
dots: M2(22–62) in the presence of 100 μMamantadine. Inset: Linear regression of data
from addition of valinomycin until initial pH change of 0.005. Slopes, after conversion of
units to H+/tetramer-s using subsequent back titrations, are reported. pHo 6.0; strong
citrate buffer external; initial slope measured 8 s after valinomycin addition based on
back-titration settling time.liposomes in 100 μM amantadine, the initial ﬂux with amantadine is
calculated to be 8.7 H+/tetramer-s. Thus, amantadine treatment reduced
transport to 26% of the original level, i.e.74% block for the experiment
shown in Fig. 2.
To assess theoligomerizationofM2(22–62), theproton transport rate
as a function of protein densitywasmeasured. Fig. 3 shows the log of the
initial liposomal proton-uptake rate after valinomycin injection (H+/s)
plotted against log of peptide content (nmol of tetramer in the 3-ml
assay). The theoretical line of unity slope shows the best ﬁt of a line
constrained topass through theoriginona linear–linearplot,witha slope
of 23.8 H+/tetramer-s after gating/orientation correction.
To test selectivity of the M2(22–62)-induced ion conductance, the
basic liposome assay paradigm was modiﬁed to allow increased
amounts of time between liposome acidiﬁcation and valinomycin
addition (5, 15, and 30 min),which is then followed 2 min later by CCCP
addition and subsequently by back-titration tests as usual. Degradation
of the total proton-uptake signal (i.e. the sum of the valinomycin and
CCCP signals, taken as the pH change from just before valinomycin
addition to just before back-titration with acid addition) is presumably
due toK+ leakage out of the liposomes between the time of dilution and
the time of CCCP addition.We therefore take total proton-uptake signal
as a proxy of K+ efﬂux. Speciﬁcally, based on dynamic steady state
modeling of relaxation to Donnan equilibrium [12], we make the
simplifying assumption that for conditions of selective potassium and
proton permeability, K+ efﬂux through M2 leads to an equivalent
reduction in the possible total proton-uptake signal height.
To a certain extent, the K+ leaks through the lipid aswell as through
the M2 transporter, as is demonstrable with protein-free liposomes.
Fig. 4 shows raw data demonstrating rundown of total proton uptake
into liposomes after addition of valinomycin and CCCP at varying time
intervals. The initial drift before addition of valinomycin is strong in
these experiments because of the low buffering capacity of the external
bath. It is only observed in the presence of liposomes (the electrode
response is very rapid) and is therefore interpreted to represent uptake
of protons by liposomes. The external pH at the time of valinomycin
injection is given on the plot and is approximately the same for each
experiment. The upper group of three traces shows decay in the height
of the total signalwithM2(22–62) present for longer delays. This is also
seen with the protein-free liposomes in the lower three traces, but the-3
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Fig. 3. Log–log representation of M2(22–62) initial proton ﬂux (mean±S.D., N=3
except for the middle point, where N=2) with varying protein content expressed as
nmol of tetramer in the assay cuvette (using a monomeric molecular weight of 5 kDa)
incorporated into 300 μg lipid. Theoretical line with unity slope: best ﬁt of the four left-
hand points to a straight line constrained to pass through the origin (y=mx). The least-
squares-ﬁt line slope, m, after correction for orientation and gating, corresponds to a
value of 23.8 H+/tetramer-s. The points correspond to 0.05% (peptide mass as a
percentage of lipid mass) at the far left and 1.0% at the far right. pHo 6.7–7.1.
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Fig. 4. pH traces with varying delays after acidiﬁcation to evaluate total liposome
proton-uptake signal rundown, (the sum of the valinomycin and the CCCP uptake
signals). Each trace is representative of a set of three equivalent experiments. pH traces
for protein-containing (black) and protein-free (gray) liposomes were aligned
vertically to start at different levels (at the arbitrary reference time of t=2 min) for
ease of comparison. The exact pH at the time of valinomycin addition for each
individual experiment is indicated next to each trace. The start time is designated as the
time of bath acidiﬁcation, which establishes a pH gradient but should only cause
minimal H+ ﬂux in the absence of antiport of K+. 0.1 mg M2(22–62):20 mg lipid:1 ml.
Internal buffer diluted 100-fold into weak external buffer. Blank-subtracted speciﬁc
activity at t=5 min: 19±4 H+/tetramer-s (N=2; pHo 6.2).
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observed, as with the central (15 min) experiment in the lower group,
but the trend of pre-valinomycin drift and decay of total signal is clear.
Fig. 5 shows the normalized average total proton-uptake signal
degradation from the experiment in Fig. 4 and two additional identical
experiments. As shown qualitatively in Fig. 4, the decay rate is lower
for the protein-free liposomes (squares) than for the proteoliposomes
(diamonds), indicating that M2 enhances K+ leakage. The average K+
ﬂux through M2(22–62) for the three experiments was 0.10 K+/-1
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Fig. 5. Logarithmic representation of total liposomal proton uptake, a proxy for effective
trapped volume, from Fig. 4. Diamonds (laterally offset for clarity) represent
proteoliposomes and squares represent protein-free liposomes. Total signal, corrected
for artifacts (measured separately) due to addition of ethanolic valinomycin and CCCP,
was normalized by extrapolation of the assumed exponential decay to 0-time total
uptakes of 143±4 nEq H+ (proteoliposomes) and 200±40 nEq H+ (protein-free
liposomes). The difference is presumably due to different decays during the 3 minute
period between dilution and acidiﬁcation, which apparently was greater for the M2
(22–62) liposomes than the protein-free liposomes, (also self-consistent with the
steeper slope for M2(22–62) liposomes). The normalization thus corrects for unequal
initial effective total trapped volumes at the time of acidiﬁcation. Total heights were
corrected by subtraction of a small proportion, 15 nEq H+ (one half the back-titration
pH change) in each case, to compensate for pH changes observed upon addition of the
effectively alkaline ethanolic reagents (valinomycin and CCCP), to liposome-free buffer.
Error bars for each point represent ±1 S.D., N=3.tetramer-s, yielding a single-channel time-average K+ efﬂux perme-
ability (K+ efﬂux/[K+]i) of 1.1×10−6 aLs−1. The single-channel time-
average proton inﬂux permeability (H+ inﬂux/[H+]o) was 40 aLs−1.
One estimate of the permeability ratio is the product of the ratio of
these efﬂux and inﬂux permeabilities, 2.8×10−8, and the electric
driving force ratio, which equals 100 (the K+ dilution factor).
Neglecting the rundown of the membrane potential, this product
gives a net electrochemical permeability ratio of 2.8×10−6.
Results of a range of liposome proton ﬂux experiments performed at
pHs ranging from 6.5 to 4.0 are plotted in Fig. 6. The ﬂux increases with
decreasing pHo down to pH 5.5, but then drops abruptly. With
amantadine present, the ﬂux is ~80% blocked at pH 5.5. At pH 6.5, the
interexperimental errors are too large to detect block in this set of
experiments, so it is not possible to compare these results to those in
Fig. 1, but there is clear evidence of block at the lower pH levels. Protein-
free liposomes ﬂuxes were small (~1 H+/tetramer-s, data not shown)
and were subtracted. Transport rises following a theoretical binding
curve having a pK of 6.0, and a maximum ﬂux of 170 H+/tetramer-s.4. Discussion
As has been demonstrated previously for M2(18–60) [13] and M2
(19–62) [3], M2(22–62) has proton ﬂux activity, amantadine sensitivity,
and H+ selectivity similar to the full-length protein. The proton initial
ﬂux per tetramer is higher than in prior liposome assay reports using
either full-length M2 [3,11] or similar conductance domain constructs
[3,13], due in part to the use here of dual gradients: pH and Vm. The
peptide is acid activated and yields higher transport rates at low external
pH, but ceases to function belowpH5.5,whichwe interpret tomean that
transporter function is disrupted at low pH, consistent with a decrease
(for decreasing pH) in the tetramerization constant for the TMD in
detergentmicelles [26]. Because the liposome interior starts at pH8.0, the
assumption that tetramers with N-terminus inside (presumably half the
total [11]) are gated closed [5,6,9,18] seems justiﬁed for the initial-ﬂux
period. However, complete blockhas not been conﬁrmed in the liposome
environment, and in erythroleukemia cells Weybridge M2 is only
blocked 50% [18]. Peptide density affects speciﬁc activity. At the lowest
density tested (0.05% peptide weight relative to lipid weight, or 4
tetramers per 150-nm diameter liposome), speciﬁc activity was
diminished, consistent with diminished tetramericity [28], but not0
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Fig. 6. Acid activation ofM2(22–62) (squares). Protonﬂuxmeasurementswere donewith
pHo of 6.5 to 4.0. For experiments with amantadine (circles), liposomeswere incubated in
0.1 mMamantadine overnight, and external buffer contained 0.1 mMamantadine aswell.
Protonﬂuxmeasurementswere corrected for baselineH+ leakage into the liposomesprior
to valinomycin addition, and for valinomycin-induced H+ leak observed in protein-free
liposomes. Fluxes are doubled as a correction for protein orientation and gating. The
saturation curve was ﬁtted with a pKa of 6.0, and a maximum ﬂux of 170 H+/tetramer-s.
The error bar for each point represents±1 S.E., calculated as the square root of the sum of
the standard errors of the means for the test group and the control (protein-free
liposomes) group. From left to right, N=6, 5, 6, 9, 8, and 4 for the protein; N=3, 3, 2, 3, 3,
and 3 for the amantadine experiments. Strong external citrate buffer was used. Nominal
membrane potential:−114 mV;pHi=8.0.
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non-speciﬁc transport depolarizes the liposomes prematurely. This
would be consistent with disruption of membrane integrity, perhaps
by lateral aggregation of tetramers. The optimal density for the external
pH assay was determined to be a protein:lipid (wt:wt) ratio of 1:200.
Total signal degradation was used to estimate M2(22–62) K+ transport
and found to be small, considering the potassium concentration inside
the liposomes, yet high enough to largely depolarize the vesicles on the
30 minute time scale. Amantadine and cyclooctylamine were found to
inhibit transport by 61 and 50%, respectively, at very low concentrations
(10 μM), as would be expected for a single site binding isotherm with
Ki=9 μM [19]. Acid activationwas demonstrated for the ﬁrst time in the
liposomeassayusingacidic external solution. Themaximal activity of139
protons/tetramer-s (Fig. 6) was observed at pH 5.5. Possible protein
destabilization or desensitization, or liposome depolarization eliminated
protonﬂux at lower pHs. Thismay have inﬂuenced the parameters of the
ﬁtting function, so themaximumﬂux rate of N160 H+/tetramer-s should
be taken as a conservative estimate. The amantadine block was most
accurately determined at pH 5.5 where it was 78%.
4.1. Analysis of uncertainties
We observe variations, from experiment to experiment, in the
shape of the valinomycin and CCCP peaks, the baseline drift, and to a
lesser extent in the shape of the back-titration pH drop. We take the
shape of the back-titration as an indication of variations in stirring.
Typically, the back-titration settles in about 2 s. Initial ﬂux is taken
from the linear portion of the valinomycin peak, typically 2–7 s post
valinomycin addition. This approach is based on the assumption that
the valinomycin peak shape is a single exponential, but in some
experiments there appear to be multiple exponentials, perhaps
representing embedded compartments. We also observe substantial
baseline drift before addition of valinomycin, probably due to the low
intrinsic lipid permeability to both protons and potassium ions. In
addition to variations in signal shapes in the liposome assays, two
major sources of uncertainty, unaddressed to date, might affect the
speciﬁc activity estimates: liposome activity and protein functionality.
For liposomes to be fully functional, they must be conﬁgured to hold a
membrane potential, namely they must be enclosed shells imperme-
able to the ions. Likewise, any protein not forming parallel tetramers
(e.g. monomers, dimers, surface-associated protein, or protein
dissolved in water or lost in extrusion) would contribute no ﬂux in
the assay. There is also some decay in the polarization of the
liposomes after dilution and/or acidiﬁcation and decay in the apparent
initial ﬂux during the dead time. These uncertainties all lead to
underestimation of the speciﬁc activity, so the values presented here
represent lower bounds.
We note that amantadine concentrations reported here are total
concentrations with no correction for lipid binding. The partition
constant of amantadine in charged phosphocholine bilayers is 84 [29].
Because the E. coli lipid bears a similar amount of charge, we estimate
that the aqueous concentration of amantadine in the experiments
reported here was only reduced by ~1.7% due to lipid binding.
4.2. Comparison to previous results
The speciﬁc transport rate of full-lengthM2 in oocytes was initially
reported [16] as 0.5 fA (3100 protons/tetramer-s) at Vm=−130 mV,
pHo 6.2, pHi~7.4. However, the reported measurements of protein
density and total oocyte conductance were subsequently reevaluated
[11] and shown to indicate a time-average single-channel proton
current of 34 aA (210 protons/tetramer-s). This time-average conduc-
tance is low, but is actually higher than one might expect for an open
gramicidin channel, which should conduct 127 aA at (symmetrical)
pH 6.2, −130 mV (assuming linear extrapolations from 7.7 pA in
phosphatidylcholine bilayers with 0.1 N HCl at 50 mV [30] to lower[H+] and more negative Vm). Considering the Po for gA under similar
phospholipid environment conditions, 0.027 [31], the time-averaged
gA currentwould bepredicted to be 3.4 aA, ten times lower thanM2.At
the pH levels attainable in cellular systems, M2 does not produce the
membrane current noise expected for on–off oscillations of pS-
conductance and noise analysis suggested a single-channel current
below 10 fA [6]. The time-average single-channel K+ current reported
here, at 0.1 ions/s, i.e. 1.6×10−8 pA, would also be undetectable using
single-channel current measurements or noise analysis. Hence, the
proton transport rates observed with the liposome assay here are not
inconsistent with aqueous pore expectations for a proton-selective
channel. Nevertheless, we favor the use of the term “proton
transporter” [9] because of the apparent saturation of transport at
modest [H+] levels [6,32]. The permeability of M2(22–62) to K+,
relative to H+ determined quantitatively here from the total signal
decay (2.8×10−6) is consistent with the lower bound on selectivity
(3×10−7) determined previously from short time scale experiments
with liposomes [11].
The proton-uptake rates observed in our liposome assays are higher
thanpreviously published, perhaps because previouswork relied only on
amembrane potential driving force [11,12] or only on a pH gradient [13],
and here both gradients are applied. In liposome assays, reconstituted
full-length Udorn inﬂuenza A M2 protein was found to be randomly
oriented in liposomes and to transport protons selectively and with
typical amantadine sensitivity at transport rates of 7 protons/tetramer-s
[11] (efﬂux, with symmetric pH~7.4 and Vm=150 mV, 18 °C), 4.8
protons/tetramer-s (inﬂux, symmetric pH 7.4, Vm=−120 mV, 18 °C)
[3] or lower [12]. Changing pH symmetrically to 5.7 enhanced
conductance (reported Vm=−94 mV), to 17 protons/tetramer-s [11].
But, for these experiments,wewould argue that themembrane potential
set by the outward sodium gradient (if monensin transport dominates),
would be −150 mV or −131 mV, depending on the dilution that was
used, and that the thermodynamic driving force due to the H+ gradient,
−94 mVwould add to the electrical potential. Therefore, the increase in
currentmay not have corresponded to as great a conductance increase as
presented because the driving force was considerably higher as well.
Nevertheless, therewas an increase in transporter activity at lowpH. The
isolated transmembrane domain, M2(20– or 22–46), yielded a similar
proton uptake in the liposome assay [3,13,33]. Longer constructs yielded
transport rates of 6.5 protons/tetramer-s (M2(18–60) with symmetrical
K+ and valinomycin, pHo=6.1, pHi=7.7, presumably at room temper-
ature) [13] and2.3protons/tetramer-s (M2(19–62)with symmetrical pH
7.4, Vm=−120 mV, 18 °C) [3]. In all but one [3] of the aforementioned
reports of liposome transport rates to date, themeasured speciﬁc activity
has been doubled to yield an apparent speciﬁc activity that accounts for
the assumed random orientation of the tetramers and N-terminal acid
gating. The results reported here indicate that the transport rate in
liposomes is considerably higher, and may be higher still when
uncertainties about liposome and protein activity are settled. The high
internal pHmight be key to the high proton inﬂuxwe observed at pH 5.5
(139 H+/tetramer-s), as previous liposome experiments with symmet-
rical pH 5 did not produce such a large proton uptake [11,12]. The
transport rate under conditions (pHo 6.0, pHi 8.0,−114 mV) nearest to
those used for measuring speciﬁc activities in the oocytes is 78±14 (SE,
N=6) H+/tetramer-s, approaching the reevaluated value for oocytes,
210 H+/tetramer-s [11].5. Conclusions
The truncated M2(22–62) protein shows normal functionality for
proton ﬂux activity when compared to the full-length M2 protein,
including amantadine and cyclooctylamine sensitivity, acid activation,
and proton selectivity. When combined pH and voltage gradients and
low protein density are used, single-channel proton transport rates
approach those observed in oocytes.
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